AKBA Akebia Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 5, 2026
$0.87
· % 处于52周区间
· 高于低点
· 至高点
$0.8152周低点
$3.2052周高点
市值 (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
收入 (TTM)
$219M
AKBA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.86
市值 (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
收入 (TTM)
$219M
ROE (TTM)
-109.4%
负债/权益 (MRQ)
2.0
52周区间
$1–$3
AKBA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$236M2020-12-31 → 2025-12-31
EPS$-0.022020-12-31 → 2025-12-31
自由现金流$68M2020-12-31 → 2025-12-31
净利率-13.5%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | AKBA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -7.95年均值 ≈-22.9 | ≈-22.9 | · | · | |
| P/S (TTM) | 1.15年均值 ≈1.9 | ≈1.9 | 26.3 | 低估 | |
| 市净率 (MRQ) | 9.45年均值 ≈-1.2 | ≈-1.2 | 2.9 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | 4.05年均值 ≈-0.3 | ≈-0.3 | · | · | |
| 股价/自由现金流 (TTM) | 5.85年均值 ≈-4.8 | ≈-4.8 | · | · | |
| 市现率 (TTM) | 5.75年均值 ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue (市值/营收) | 0.45年均值 ≈1.7 | ≈1.7 | · | · | |
| EV / FCF (市值/自由现金流) | 1.45年均值 ≈-5.3 | ≈-5.3 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | AKBA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -6.9%5年均值 ≈-18.2% | ≈-18.2% | -472.2% | 顶尖 | |
| EBITDA Margin (息税折旧摊销前利润率) | 10.0%5年均值 ≈-18.1% | ≈-18.1% | -469.9% | 顶尖 | |
| 税前利润率 (TTM) | -12.7%5年均值 ≈-26.0% | ≈-26.0% | -115.1% | 顶尖 | |
| 净利润率 (TTM) | -13.5%5年均值 ≈-26.1% | ≈-26.1% | -420.3% | 顶尖 | |
| ROA (TTM) | -8.5%5年均值 ≈-17.2% | ≈-17.2% | -28.8% | 顶尖 | |
| ROE (TTM) | -109.4%5年均值 ≈90.2% | ≈90.2% | -36.9% | 顶尖 | |
| ROIC | 41.7% | · | 0.40% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | AKBA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 2.05年均值 ≈-0.1 | ≈-0.1 | · | · | |
| 流动比率 (MRQ) | 1.45年均值 ≈1.4 | ≈1.4 | 5.9 | 低流动性 | |
| Quick Ratio (速动比率) | 1.45年均值 ≈1.1 | ≈1.1 | 5.5 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 1.05年均值 ≈0.0 | ≈0.0 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | AKBA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 47.5%5年均值 ≈8.6% | ≈8.6% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -6.9%5年均值 ≈-9.6% | ≈-9.6% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -4.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | AKBA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.85年均值 ≈0.7 | ≈0.7 | 0.2 | 顶尖 | |
| Inventory Turnover (库存周转率) | 2.55年均值 ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (应收账款周转率) | 5.85年均值 ≈5.6 | ≈5.6 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.2M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
49.6%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $-0.03 | $-0.04 | 33.2% |
| 2026年3月31日 | 五月 11, 2026 | $-0.03 | $-0.03 | -4.9% |
| 2025年12月31日 | $-0.05 | $-0.03 | -96.1% | |
| 2025年9月30日 | $0.00 | $-0.02 | 100.0% | |
| 2025年6月30日 | $0.00 | $-0.02 | 100.0% | |
| 2025年3月31日 | $0.03 | $-0.05 | 165.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $-0.22 | $-0.16 | · | $0.43 | $1.67 | $3.24 | $5.44 | $2.51 | $1.76 | $4.27 | $5.11 | |
| Revenue / Share | $0.92 | $0.76 | $1.04 | $1.60 | $1.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.26 | $-0.19 | $-0.12 | $-0.40 | $-1.52 | · | · | · | · | · | · | · | |
| Cash / Share | $0.70 | $0.23 | $0.22 | · | $0.85 | $1.54 | $1.21 | $0.90 | $1.47 | $4.85 | $1.62 | $1.61 | |
| EPS (TTM) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | $-1.86 | $-1.86 | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | · | 264,786,432 | 262,565,500 | 235,497,720 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | · | 274,372,722 | 271,104,020 | 241,602,853 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.10 | · | $0.16 | $0.11 | $0.09 | · | $-0.24 | $-0.16 | $-0.13 | · | $-0.21 | $-0.14 | $-0.08 | · | $0.08 | |
| Revenue / Share | $0.18 | $0.20 | · | $0.21 | $0.23 | $0.24 | · | $0.18 | $0.21 | $0.16 | · | $0.22 | $0.30 | $0.22 | · | $0.27 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.57 | $0.61 | · | $0.63 | $0.52 | $0.43 | · | $0.16 | $0.19 | $0.20 | · | $0.25 | $0.28 | $0.31 | · | $0.79 | |
| EPS (TTM) | $-0.11 | $-0.08 | · | $-0.07 | $-0.17 | $-0.21 | · | $-0.22 | $-0.20 | $-0.22 | · | $-0.32 | $-0.53 | $-0.32 | · | $-0.89 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $232M | · | $225M | $204M | $185M | · | $170M | $174M | $187M | · | $194M | $201M | $271M | · | $294M | |
| Net Income TTM | $-30M | $-21M | · | $-16M | $-36M | $-45M | · | $-46M | $-40M | $-43M | · | $-59M | $-98M | $-58M | · | $-158M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -10.4 | -17.4 | · | -39.0 | -21.4 | -9.1 | · | -6.0 | -5.1 | -8.3 | · | -3.6 | -1.7 | -1.8 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.2 | 4.7 | 2.7 | · | 1.6 | 1.2 | 2.0 | · | 1.1 | 0.9 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.7 | 4.3 | 2.4 | · | 1.7 | 1.2 | 2.0 | · | 1.1 | 0.8 | 0.4 | · | -0.1 | |
| Earnings Yield | -9.7% | -5.8% | · | -2.6% | -4.7% | -10.9% | · | -16.7% | -19.6% | -12.0% | · | -28.1% | -57.9% | -57.1% | · | -281.6% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| 收入 | $236M | $160M | $195M | · | $292M |
| 营业利润率 % | 10.0% | -31.5% | -23.8% | · | -27.6% |
| 净收入 | $-5M | $-69M | $-52M | · | $-94M |
| 稀释后每股收益 (EPS) | $-0.02 | $-0.33 | $-0.28 | · | $-0.52 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 1.5 | -0.8 | -1.1 | · | · |
| 流动比率 | 1.6 | 1.4 | 1.2 | · | · |
| 速动比率 | 1.4 | 1.1 | 0.8 | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $68M | $-41M | $-23M | · | $-73M |
机构持有人 (13F) 180 家申报者 · $144.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
180
持有价值
$144.4M
新仓位
39
已退出持仓
35
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 39 (+4 与上一季度对比) | 35 (+8 与上一季度对比) | 68 (+25 与上一季度对比) | 34 (-20 与上一季度对比) | +6.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $25786481 | 16016448 | 17.86% | 股份 |
| BlackRock, Inc. | $22784466 | 19986374 | 15.78% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $12907243 | 11322143 | 8.94% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $10432737 | 9151524 | 7.23% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $7671148 | 6727302 | 5.31% | 股份 |
| STATE STREET CORP | $6145572 | 5390853 | 4.26% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4871250 | 4273026 | 3.37% | 股份 |
| GOLDMAN SACHS GROUP INC | $4205650 | 3689167 | 2.91% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $3644130 | 3196605 | 2.52% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2888734 | 2533977 | 2.00% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2777807 | 2436673 | 1.92% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2622499 | 2300438 | 1.82% | 股份 |
| NORTHERN TRUST CORP | $2462816 | 2160365 | 1.71% | 股份 |
| Nantahala Capital Management, LLC | $2280000 | 2000000 | 1.58% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $2176029 | 1908797 | 1.51% | 股份 |
| FMR LLC | $2133008 | 1871059 | 1.48% | 股份 |
| Qube Research & Technologies Ltd | $2028866 | 1779707 | 1.41% | 股份 |
| CITADEL ADVISORS LLC | $1958131 | 1717659 | 1.36% | 股份 |
| UBS Group AG | $1567442 | 1374950 | 1.09% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1395318 | 1223963 | 0.97% | 股份 |
| CITIGROUP INC | $1282010 | 1124570 | 0.89% | 股份 |
| MORGAN STANLEY | $799756 | 701540 | 0.55% | 股份 |
| Invesco Ltd. | $792218 | 694928 | 0.55% | 股份 |
| MANGROVE PARTNERS IM, LLC | $760328 | 666954 | 0.53% | 股份 |
| AMERIPRISE FINANCIAL INC | $713823 | 626160 | 0.49% | 股份 |
| Bank of New York Mellon Corp | $705830 | 619149 | 0.49% | 股份 |
| Nuveen, LLC | $680123 | 596599 | 0.47% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672396 | 589821 | 0.47% | 股份 |
| TWO SIGMA ADVISERS, LP | $643918 | 399949 | 0.45% | 股份 |
| CHOREO, LLC | $641162 | 562423 | 0.44% | 股份 |
| Quantinno Capital Management LP | $640820 | 562123 | 0.44% | 股份 |
| Creative Planning | $622144 | 545740 | 0.43% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606265 | 531813 | 0.42% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $531832 | 466519 | 0.37% | 股份 |
| BANK OF AMERICA CORP /DE/ | $522976 | 458750 | 0.36% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $493325 | 354910 | 0.34% | 股份 |
| Eversept Partners, LP | $486888 | 427095 | 0.34% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $408376 | 358627 | 0.28% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $368904 | 323600 | 0.26% | 股份 |
| VIRTUS ADVISERS, LLC | $359940 | 315737 | 0.25% | 股份 |
| RHUMBLINE ADVISERS | $350544 | 307503 | 0.24% | 股份 |
| Russell Investments Group, Ltd. | $342416 | 300367 | 0.24% | 股份 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336186 | 294900 | 0.23% | 股份 |
| ALPS ADVISORS INC | $310379 | 272262 | 0.21% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304722 | 267300 | 0.21% | 卖出期权 |
| JPMORGAN CHASE & CO | $298634 | 269040 | 0.21% | 股份 |
| DEUTSCHE BANK AG\ | $292847 | 256883 | 0.20% | 股份 |
| FRANKLIN RESOURCES INC | $286156 | 251014 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279072 | 244800 | 0.19% | 买入期权 |
| WELLS FARGO & COMPANY/MN | $270084 | 236916 | 0.19% | 股份 |
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 申报 | 2019年1月11日 | · | 初始申报 | 并购/出售 | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 申报 | 2018年12月21日 | · | 初始申报 | 被动投资 | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 申报 | 2017年8月10日 | · | 初始申报 | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 申报 | 2016年1月20日 | · | 初始申报 | · | SEC |
| Novo A/S ×3 申报 | 2015年11月18日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 38 位内幕人士 · 17 位高管 · 20 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| John P. Butler | CEO and President | 2026年8月6日 M | 3718564 | 1 | 4 | $-387825 |
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 2026年6月29日 S | 616616 | 0 | 2 | $-110763 |
| Ellen Snow | SVP, CFO and Treasurer | 2024年1月31日 A | 519300 | 0 | 0 | $0 |
| David A Spellman | SVP, CFO and Treasurer | 2023年5月16日 S | 446483 | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 2020年2月28日 A | 144642 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Operating Officer | 2024年5月13日 S | 672092 | 0 | 0 | $0 |
| Carolyn M. Rucci | SVP, Chief Legal Officer | 2026年2月2日 S | 588378 | 0 | 3 | $-96983 |
| Richard C Malabre | SVP, Chief Accounting Officer | 2026年2月2日 S | 299390 | 0 | 2 | $-68838 |
| Nicholas Grund | Chief Commercial Officer | 2026年2月2日 S | 561750 | 0 | 2 | $-117912 |
| Steven Keith Burke | SVP, Chief Medical Officer | 2026年2月2日 S | 948432 | 0 | 3 | $-94044 |
| Nicole R. Hadas | SVP, Chief Legal Officer | 2024年5月13日 S | 651243 | 0 | 0 | $0 |
| Violetta Cotreau | SVP, Chief Accounting Officer | 2022年5月12日 A | 219954 | 0 | 0 | $0 |
| Dell Faulkingham | SVP, CCO | 2022年2月28日 A | 173841 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 2020年2月28日 A | 84679 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 2019年4月11日 D | 96332 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 2017年2月21日 A | 64585 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 2014年5月14日 A | 264556 | 0 | 0 | $0 |
| Ron Frieson | 董事 | 2026年6月17日 A | 165200 | 0 | 0 | $0 |
| Myles Wolf | 董事 | 2026年6月17日 A | 169081 | 0 | 0 | $0 |
| Cynthia Smith | 董事 | 2026年6月17日 A | 196633 | 0 | 0 | $0 |
| Adrian Adams | 董事 | 2026年6月17日 A | 236200 | 0 | 0 | $0 |
| Michael W Rogers | 董事 | 2026年6月17日 A | 197429 | 0 | 0 | $0 |
| Leanne M Zumwalt | 董事 | 2026年6月17日 A | 145100 | 0 | 0 | $0 |
| Philip J. Vickers | 董事 | 2026年4月1日 A | · | 0 | 0 | $0 |
| Steven C Gilman | 董事 | 2025年6月10日 A | 152830 | 0 | 0 | $0 |
| Michael Thomas Heffernan | 董事 | 2021年6月2日 A | 48586 | 0 | 0 | $0 |
| Mark J Enyedy | 董事 | 2020年6月5日 A | 31143 | 0 | 0 | $0 |
| Maxine Gowen | 董事 | 2020年6月5日 A | 24133 | 0 | 0 | $0 |
| Jodie Pope Morrison | 董事 | 2019年6月6日 A | 58619 | 0 | 0 | $0 |
| Scott A Canute | 董事 | 2019年6月6日 A | 13700 | 0 | 0 | $0 |
| Michael D. Clayman | 董事 | 2018年6月14日 A | · | 0 | 0 | $0 |
| Duane Nash | 董事 | 2018年6月14日 A | 21499 | 0 | 0 | $0 |
| Ronald C Renaud JR | 董事 | 2018年6月14日 A | 5000 | 0 | 0 | $0 |
| Satter Muneer A | 董事 | 2018年6月14日 A | 3037042 | 0 | 0 | $0 |
| Michael S Wyzga | 董事 | 2018年6月14日 A | 1500 | 0 | 0 | $0 |
| Anupam Dalal | 董事 | 2016年6月16日 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | · | 2014年3月25日 C | 1516387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | · | 2014年3月25日 C | 3405764 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 17 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.52% | 130501 SH | 2026年10月1日 | 每日 |
| IWC · iShares Trust | 0.06% | 873651 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 249458 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 451303 SH | 2026年10月1日 | 每日 |
| IWO · iShares Trust | 0.01% | 2169896 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 123445 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 1485665 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 6668524 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.00% | 364328 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 46198 SH | 2026年9月3日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 3164884 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 7912283 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 24210 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 20230 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 754414 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 338893 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 623464 SH | 2026年9月11日 | 每日 |
AKBA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 11 位分析师
买入
中位数目标
$4.00
+362.4%
4 36.4%
强烈买入
5 45.5%
买入
2 18.2%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
6 位分析师 · 2026-10-03平均目标 $3.92 +352.8%
← 低于所有目标
当前价格 $0.86
最低$1.00
平均值$3.92
最高$6.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报